Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 3/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | CNR1 | P21554 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.32 |
| ▸ | HTR2A | P28223 | 1/20 | 0.32 |
| ▸ | HTR2C | P28335 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15083742 | 0.81 | TSHR (0.36) | TSHRLMNAMEN1KMT2AUSP2 | |
| SCHEMBL13115051 | 0.81 | TSHR (0.36) | TSHRLMNAMEN1KMT2AUSP2 | |
| SCHEMBL15203352 | 0.81 | MMP8 (0.37) | TSHRLMNAMEN1KMT2AUSP2 | |
| SCHEMBL15184278 | 0.80 | MMP8 (0.31) | MMP8 | |
| SCHEMBL14905847 | 0.80 | — | — | |
| SCHEMBL13350013 | 0.80 | DGAT1 (0.46) | TSHRLMNACYP3A4HPGDMAPK1 | |
| SCHEMBL17617203 | 0.80 | DGAT1 (0.46) | TSHRLMNACYP3A4HPGDMAPK1 | |
| SCHEMBL17617208 | 0.78 | MMP8 (0.46) | TSHRLMNAMEN1KMT2AABCB11 | |
| SCHEMBL10244061 | 0.78 | MMP8 (0.46) | TSHRLMNAMEN1KMT2AABCB11 | |
| SCHEMBL17617170 | 0.77 | TSHR (0.40) | TSHRLMNAMEN1KMT2AUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101276936-A | Non-aqueous electrolyte secondary cell | SANYO ELECTRIC CO (JP) | 2008-10-01 | — | — | CN | claimed |
| US-20160083341-A1 | METHOD FOR PRODUCING a-SUBSTITUTED CYSTEINE OR SALT THEREOF OR SYNTHETIC INTERMEDIATE OF a-SUBSTITUTED CYSTEINE | API CORPORATION (JP) | 2016-03-24 | — | — | US | disclosed |
| WO-2012142059-A2 | PARTICLES COMPRISING VOLATILE MATERIALS AND PARTICLE GAS SATURATED SOLUTION PROCESSES FOR MAKING SAME | THE PROCTER & GAMBLE COMPANY (US) | 2012-10-18 | — | — | WO | disclosed |
| US-20120258150-A1 | PARTICLES COMPRISING VOLATILE MATERIALS AND PARTICLE GAS SATURATED SOLUTION PROCESSES FOR MAKING SAME | THE PROCTER & GAMBLE COMPANY | 2012-10-11 | — | — | US | disclosed |
| US-20100287710-A1 | PERFUME SYSTEMS | THE PROCTER & GAMBLE COMPANY | 2010-11-18 | — | — | US | disclosed |
| CN-101276936-A | Non-aqueous electrolyte secondary cell | SANYO ELECTRIC CO (JP) | 2008-10-01 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160083341-A1 | METHOD FOR PRODUCING a-SUBSTITUTED CYSTEINE OR SALT THEREOF OR SYNTHETIC INTERMEDIATE OF a-SUBSTITUTED CYSTEINE | MGMT, GSTA1, CBS | TSHR 1898/4885LMNA 4014/4885MEN1 3023/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.